Chapman JD - Search Results

1

Prediction of tumour hypoxia and radioresistance with nuclear medicine markers.

Chapman JD, Coia LR, Stobbe CC, Engelhardt EL, Fenning MC, Schneider RF. Chapman JD, et al. Br J Cancer Suppl. 1996 Jul;27:S204-8. Br J Cancer Suppl. 1996. PMID: 8763881 Free PMC article.

2

The synthesis and radiolabeling of 2-nitroimidazole derivatives of cyclam and their preclinical evaluation as positive markers of tumor hypoxia.

Engelhardt EL, Schneider RF, Seeholzer SH, Stobbe CC, Chapman JD. Engelhardt EL, et al. Among authors: chapman jd. J Nucl Med. 2002 Jun;43(6):837-50. J Nucl Med. 2002. PMID: 12050331 Free article.

3

Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays.

Chapman JD, Engelhardt EL, Stobbe CC, Schneider RF, Hanks GE. Chapman JD, et al. Radiother Oncol. 1998 Mar;46(3):229-37. doi: 10.1016/s0167-8140(97)00186-2. Radiother Oncol. 1998. PMID: 9572615 Review.

4

A dual hypoxic marker technique for measuring oxygenation change within individual tumors.

Iyer RV, Kim E, Schneider RF, Chapman JD. Iyer RV, et al. Among authors: chapman jd. Br J Cancer. 1998 Jul;78(2):163-9. doi: 10.1038/bjc.1998.459. Br J Cancer. 1998. PMID: 9683288 Free PMC article.

5

Preclinical assessment of hypoxic marker specificity and sensitivity.

Iyer RV, Engelhardt EL, Stobbe CC, Schneider RF, Chapman JD. Iyer RV, et al. Among authors: chapman jd. Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):741-5. doi: 10.1016/s0360-3016(98)00315-0. Int J Radiat Oncol Biol Phys. 1998. PMID: 9845088

6

Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio.

Nahum AE, Movsas B, Horwitz EM, Stobbe CC, Chapman JD. Nahum AE, et al. Among authors: chapman jd. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):391-401. doi: 10.1016/s0360-3016(03)00534-0. Int J Radiat Oncol Biol Phys. 2003. PMID: 12957250

7

Nuclear magnetic resonance spectroscopy and sensitizer-adduct measurements of photodynamic therapy-induced ischemia in solid tumors.

Chapman JD, McPhee MS, Walz N, Chetner MP, Stobbe CC, Soderlind K, Arnfield M, Meeker BE, Trimble L, Allen PS. Chapman JD, et al. J Natl Cancer Inst. 1991 Nov 20;83(22):1650-9. doi: 10.1093/jnci/83.22.1650. J Natl Cancer Inst. 1991. PMID: 1749018

8

The role of specific reductases in the intracellular activation and binding of 2-nitroimidazoles.

Joseph P, Jaiswal AK, Stobbe CC, Chapman JD. Joseph P, et al. Among authors: chapman jd. Int J Radiat Oncol Biol Phys. 1994 May 15;29(2):351-5. doi: 10.1016/0360-3016(94)90288-7. Int J Radiat Oncol Biol Phys. 1994. PMID: 8195032

9

The intrinsic radiosensitivity of some human tumor cells throughout their cell cycles.

Biade S, Stobbe CC, Chapman JD. Biade S, et al. Among authors: chapman jd. Radiat Res. 1997 Apr;147(4):416-21. Radiat Res. 1997. PMID: 9092920

10

Condensed chromatin and cell inactivation by single-hit kinetics.

Chapman JD, Stobbe CC, Gales T, Das IJ, Zellmer DL, Biade S, Matsumoto Y. Chapman JD, et al. Radiat Res. 1999 Apr;151(4):433-41. Radiat Res. 1999. PMID: 10190495

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

475 results

Search Page

Filters